The tweet was deleted by the author.
But we saved everything 🙂.
Accuray is inviting attendees to book one-on-one demonstrations of its CyberKnife stereotactic and helical radiation therapy platforms during the ESTRO26 event.
The company highlights limited availability for these demo sessions, signaling strong interest and engagement opportunities at the congress. ESTRO26 serves as a major platform for oncology professionals to explore advanced treatment solutions, positioning Accuray to engage directly with industry specialists.
Accuray previously presented its Radixact and Helix systems for flexible helical radiotherapy at ESTRO26. In earlier research, Accuray reported that helical TomoTherapy could deliver less xerostomia compared to VMAT in advanced nasopharyngeal carcinoma, citing improved sparing of the parotid gland in a company study. The company's ongoing event participation highlights continued interest in precision radiation technology.